AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Matteo Santoni'
:
Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells
Publication Year: 2015
DOI: https://doi.org/10.18632/oncotarget.5768
Abstract:
Add to Library
Authors:
Maria Beatrice Morelli
Consuelo Amantini
Matteo Santoni
Alessandra Soriani
Massimo Nabissi
Claudio Cardinali
Angela Santoni
Giorgio Santoni
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
Publication Year: 2016
DOI: https://doi.org/10.18632/oncotarget.10515
Abstract:
Add to Library
Authors:
Cristian Lolli
Umberto Basso
Lisa Derosa
Emanuela Scarpi
Teodoro Sava
Matteo Santoni
Simon J. Crabb
Francesco Massari
Michele Aieta
Vincenza Conteduca
Marco Maruzzo
Francesca La Russa
Matthew Wheater
Rossana Berardi
Luca Galli
Ugo De Giorgi
Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression
Publication Year: 2016
DOI: https://doi.org/10.18632/oncotarget.9661
Abstract:
Add to Library
Authors:
Maria Beatrice Morelli
Massimo Nabissi
Consuelo Amantini
Daniele Tomassoni
Francesco Rossi
Claudio Cardinali
Matteo Santoni
Antonietta Arcella
Maria Antonietta Oliva
Angela Santoni
Carlo Polidori
Maria Paola Mariani
Giorgio Santoni
Re: Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912–4
Publication Year: 2016
DOI: https://doi.org/10.1016/j.eururo.2016.06.038
Abstract:
Add to Library
Authors:
Juan Ruíz-Bañobre
Urbano Anido
Jorge García
Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner
Publication Year: 2016
DOI: https://doi.org/10.18632/oncotarget.13769
Abstract:
Add to Library
Authors:
Maria Beatrice Morelli
Consuelo Amantini
Massimo Nabissi
Claudio Cardinali
Matteo Santoni
Giovanni Bernardini
Angela Santoni
Giorgio Santoni
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
Publication Year: 2016
DOI: https://doi.org/10.18632/oncotarget.13372
Abstract:
Add to Library
Authors:
Rossana Berardi
Matteo Santoni
Thomas Newsom-Davis
Miriam Caramanti
Silvia Rinaldi
Michela Tiberi
Francesca Morgese
Mariangela Torniai
Mirco Pistelli
Azzurra Onofri
Mark Bower
Stefano Cascinu
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma
Publication Year: 2015
DOI: https://doi.org/10.18632/oncotarget.5147
Abstract:
Add to Library
Authors:
Francesco Piva
Matteo Giulietti
Giulia Occhipinti
Matteo Santoni
Francesco Massari
Valeria Sotte
Roberto Iacovelli
Luciano Burattini
Daniele Santini
Rodolfo Montironi
Stefano Cascinu
Giovanni Principato
Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma
Publication Year: 2014
DOI: https://doi.org/10.1016/j.juro.2014.07.011
Abstract:
Add to Library
Authors:
Matteo Santoni
Alessandro Conti
Camillo Porta
Giuseppe Procopio
Cora N. Sternberg
Umberto Basso
Ugo De Giorgi
Sergio Bracarda
Mimma Rizzo
Cinzia Ortega
Francesco Massari
Roberto Iacovelli
Lisa Derosa
Cristina Masini
Michèle Milella
Giuseppe Di Lorenzo
Francesco Atzori
Maria Pagano
Sebastiano Buti
Rocco De Vivo
Alessandra Mosca
Marta Rossi
Chiara Paglino
Elena Verzoni
Linda Cerbone
Giovanni Muzzonigro
Massimo Falconi
Rodolfo Montironi
Luciano Burattini
Daniele Santini
Stefano Cascinu
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma
Publication Year: 2016
DOI: https://doi.org/10.18632/oncotarget.8302
Abstract:
Add to Library
Authors:
Daniele Santini
Matteo Santoni
Alessandro Conti
Giuseppe Procopio
Elena Verzoni
Luca Galli
Giuseppe Di Lorenzo
Ugo De Giorgi
Delia De Lisi
Maurizio Nicodemo
Marco Maruzzo
Francesco Massari
Sebastiano Buti
Emanuela Altobelli
Elisa Biasco
Riccardo Ricotta
Camillo Porta
Bruno Vincenzi
Rocco Papalia
Paolo Marchetti
Luciano Burattini
Rossana Berardi
Giovanni Muto
Rodolfo Montironi
Stefano Cascinu
Giuseppe Tonini
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
Publication Year: 2015
DOI: https://doi.org/10.18632/oncotarget.4191
Abstract:
Add to Library
Authors:
Rossana Berardi
Alessandro Brunelli
Silvia Pagliaretta
Vittorio Paolucci
Alessandro Conti
Gaia Goteri
Majed Refai
Cecilia Pompili
Giulia Marcantognini
Francesca Morgese
Z. Ballatore
Agnese Savini
M. De Lisa
Miriam Caramanti
Matteo Santoni
Antonio Zizzi
Francesco Piva
Paola Mazzanti
Azzurra Onofri
Armando Sabbatini
Marina Scarpelli
Stefano Cascinu
Prognostic Factors in Patients Receiving Third Line Targeted Therapy for Metastatic Renal Cell Carcinoma
Publication Year: 2014
DOI: https://doi.org/10.1016/j.juro.2014.11.092
Abstract:
Add to Library
Authors:
Roberto Iacovelli
Alessio Farcomeni
Cora N. Sternberg
Giacomo Cartenì
Michèle Milella
Matteo Santoni
Linda Cerbone
Giuseppe Di Lorenzo
Elena Verzoni
Cinzia Ortega
Roberto Sabbatini
Riccardo Ricotta
Caterina Messina
Vito Lorusso
Francesco Atzori
Fabio De Vincenzo
Cosimo Sacco
Francesco Boccardo
F. Valduga
Francesco Massari
Valentina Baldazzi
Saverio Cinieri
Alessandra Mosca
Enzo Maria Ruggeri
Alfredo Berruti
Giuseppe Procopio
Reply to Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912–4
Publication Year: 2016
DOI: https://doi.org/10.1016/j.eururo.2016.02.048
Abstract:
Add to Library
Authors:
Tim N. Beck
Erica A. Golemis
Daniel M. Geynisman
Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
Publication Year: 2018
DOI: https://doi.org/10.2217/fon-2018-0604
Abstract:
Add to Library
Authors:
Vincenzo Di Nunno
Lidia Gatto
Benedetta Fragomeno
Marta Cubelli
Elisabetta Nobili
Ida Romano
Matteo Santoni
Salvatore Pisconti
Rodolfo Montironi
Francesco Massari
Reply to Vincenzo Di Nunno, Matteo Santoni, Alessia Cimadamore, Nicola Battelli, and Francesco Massari's Letter to the Editor re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, et al. Updates in the Eight Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560–9
Publication Year: 2018
DOI: https://doi.org/10.1016/j.eururo.2018.07.007
Abstract:
Add to Library
Authors:
Gladell P. Paner
Mahul B. Amin
The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications
Publication Year: 2019
DOI: https://doi.org/10.3390/ijms20225683
Abstract:
Add to Library
Authors:
Gaetano Aurilio
Francesco Piva
Matteo Santoni
Alessia Cimadamore
Giulia Sorgentoni
Antonio López-Beltrán
Liang Cheng
Nicola Battelli
Franco Nolé
Rodolfo Montironi
Found 96 results in 0.123 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"